title: Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?
authors.affiliation: Poliklinik für Rheumatologie, Universitätsklinkum Schleswig-Holstein, Lübeck, Germany. bernhard.helllmich@rheuma.uni-luebeck.de
authors.forename: B
authors.initials: B
authors.lastname: Hellmich
authors.forename: I
authors.initials: I
authors.lastname: Kausch
authors.forename: C
authors.initials: C
authors.lastname: Doehn
authors.forename: D
authors.initials: D
authors.lastname: Jocham
authors.forename: K
authors.initials: K
authors.lastname: Holl-Ulrich
authors.forename: W L
authors.initials: WL
authors.lastname: Gross
mesh_terms: D003520:Cyclophosphamide / Q000009:adverse effects*; D014890:Granulomatosis with Polyangiitis / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015080:Mesna / Q000627:therapeutic use; D020011:Protective Agents / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000209:etiology* / Q000517:prevention & control
chemical_list: D007166:Immunosuppressive Agents; D020011:Protective Agents; D003520:Cyclophosphamide; D015080:Mesna